Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients

1 month ago 50

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026.

Tom Little | Reuters